Tech Company Financing Transactions
Petra Pharma Funding Round
Petra Pharma closed a $48 million Series A funding round on 1/7/2016. Investors included AbbVie Biotech Ventures, Accelerator Ventures and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
1/7/2016
Transaction Type
Venture Equity
Amount
$48,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will be used to develop small molecule inhibitors for the treatment of cancer and metabolic diseases in alliance with Weill Cornell Medicine.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
450 E. 29th St.
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Email Address
Not Recorded
Overview
Petra Pharma's approach interrogates the novel enzyme targets responsible for a variety of important cellular processes, including cell division, growth, trafficking and signaling to develop therapies to improve patient health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Lewis Cantley
Co-Founder
Nathanial Gray
Browse more venture capital transactions:
Prev: 1/7/2016: BiO2 Medical venture capital transaction
Next: 1/7/2016: Xevo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs